Interaction of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro

International Journal of Antimicrobial Agents

Volumn 29, Issue 4, 2007, Pages 424-429

  Perkhofer, Susanne ^a   Niederegger, Harald ^a   Blum, Gerhard ^a   Burgstaller, Wolfgang ^b   Ledochowski, Maximilian ^c   Dierich, Manfred P ^a   Lass Flörl, Cornelia ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Aspergillus spp.; Ergosterol; Platelets; Serotonin

Indexed keywords

ERGOSTEROL; SEROTONIN;

ARTICLE; ASPERGILLUS; CELL MEMBRANE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DRUG ACCUMULATION; DRUG UPTAKE; FUNGAL CELL; FUNGUS GROWTH; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; STEROL SYNTHESIS;

ANTIFUNGAL AGENTS; ASPERGILLUS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ERGOSTEROL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; OXIDATION-REDUCTION; PHOSPHORYLATION; SEROTONIN;

EID: 33847415824     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.12.003     Document Type: Article

References (30)

1. Denning D.W. Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host. J Antimicrob Chemother 28 Suppl. B (1991) 1-16
2. Denning D.W. Invasive aspergillosis. Clin Infect Dis 26 (1998) 781-805
3. Bauters T.G., Buyle F.M., Peleman R., and Robays H. Antifungal drugs and rational use of antifungals in treating invasive aspergillosis: the role of the hospital pharmacist. Pharm World Sci 27 (2005) 31-34
4. Peterson P.K., McGlave P., Ramsay K.C., et al. A prospective study of infectious diseases following bone marrow transplantation: emergence of Aspergillus and cytomegalovirus as the major causes of mortality. Am J Infect Control 4 (1998) 81-89
5. Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer centre and review. Clin Infect Dis 14 Suppl. 1 (1992) S43-S53
6. Mössner R., and Lesch K. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun 12 (1998) 249-271
7. O'Connell P.J., Wang X., Leon-Ponte M., Griffiths C., Pingle S.C., and Ahern G.P. A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood 3 (2006) 1010-1017
8. Hellstrand K. Hermodsson S. Serotonergic 5-HT1A receptors regulate a cell contact-media interaction between natural killer cells and monocytes. Scand J Immunol 37 (1993) 7-18
9. Schuff-Werner P., and Splettstoesser W. Antioxidative properties of serotonin and the bactericidal function of polymorphonuclear phagocytes. In: Huether G., Kochen T., Simat T.J., and Steinhart H. (Eds). Tryptophan, serotonin, and melatonin: basic aspects and applications. 1st ed. (1999), Kluwer Academic Plenum Publishers, New York 321-325
10. Lass-Flörl C., Wiedauer B., Mayr A., et al. Antifungal properties of 5-HT (serotonin) against Aspergillus spp. in vitro. Int J Med Microbiol 291 (2002) 655-657
11. Lass-Flörl C, Nussbaumer W, Dierich MP, Unterdorfer S. New insights into the role of platelets in antifungal host defense. In: 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 16-19 December 2005; Washington, DC (poster M-996).
12. Larsson M., Hagberg L., Norkrans G., and Forsman A. Indole amine deficiency in blood and cerebrospinal fluid from patients with human immunodeficiency virus infection. J Neurosci Res 23 (1989) 441-446
13. Fischer R., and Timberlake W.E. Aspergillus nidulans apsA (anucleate primary sterigmata) encodes a coiled-coil protein required for nuclear positioning and completion of asexual development. J Cell Biol 128 (1995) 485-498
14. Oberparleiter C., Kaiserer L., Haas H., et al. Active internalisation of the Penicillium chrysogenum antifungal protein in sensitive aspergilli. Antimicrob Agents Chemother 47 (2003) 3598-3601
15. Breivik O.N., and Owades J.L. Spectrophotometric semi-microdetermination of ergosterol in yeast. J Agric Food Chem 5 (1957) 360-362
16. Arthington-Skaggs B.A., Jradi H., Desai T., and Morrison C.J. Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans. J Clin Microbiol 37 (1999) 3332-3337
17. Pike B.R., Zhao X., Newcomb J.K., Glenn C.C., Anderson D.K., and Hayes R.L. Stretch injury causes calpain and caspase-3 activation and necrotic and apoptotic cell death in septo-hippocampal cell cultures. J Neurotrauma 17 (2000) 283-298
18. Zhao X., Newcomb J.K., Pike B.R., Wang K.K., d'Avella D., and Hayes R.L. Novel characteristics of glutamate-induced cell death in primary septohippocampal cultures: relationship to calpain and caspase-3 protease activation. J Cereb Blood Flow Metab 20 (2000) 550-562
19. Jones K.J., and Senft J. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. J Histochem Cytochem 33 (1985) 77-79
20. Gruber A., Lukasser-Vogl E., Borg-von Zepelin M., Dierich M.P., and Wurzner R. Human immunodeficiency virus type 1 gp160 and gp41 binding to Candida albicans selectively enhances candidal virulence in vitro. J Infect Dis 177 (1998) 1057-1063
21. Nagl M., Hengster P., Semenitz E., and Waldemar G. The postantibiotic effect of N-chlorotaurine on Staphylococcus aureus. Application in the mouse peritonitis model. J Antimicrob Chemother 43 (1999) 805-809
22. Valgus J.M. What's new in antifungals?. Curr Infect Dis Rep 5 (2003) 16-21
23. Connor S.D., and Schmid S.L. Regulated portals of entry into the cell. Nature 422 (2003) 37-44
24. Hogan L.H., Klein B.S., and Levitz S.M. Virulence factors of medically important fungi. Clin Microbiol Rev 9 (1996) 469-488
25. Mayr A., Hinterberger G., Dierich M.P., and Lass-Flörl C. Interaction of serotonin with Candida albicans selectively attenuates fungal virulence in vitro. Int J Antimicrob Agents 26 (2005) 335-337
26. Lass-Flörl C., Fuchs D., Ledochowsky M., Speth C., Dierich M.P., and Würzner R. Antifungal properties of 5-hydroxytryptamine (serotonin) against Candida species in vitro. J Med Microbiol 52 (2003) 169-171
27. Lass-Flörl C., Dierich M.P., Fuchs D., Semenitz E., Jenewein I., and Ledochowsky M. Antifungal properties of selective serotonin reuptake inhibitors against Aspergillus species in vitro. J Antimicrob Chemother 48 (2001) 775-779
28. Holmsen H., and Weiss H.J. Secretable storage pools in platelets. Annu Rev Med 30 (1979) 119-134
29. Harenberg J., Huhle G., Giese C., et al. Determination of serotonin release from platelets by enzyme immunoassay in the diagnosis of heparin-induced thrombocytopenia. Br J Haematol 109 (2000) 182-186
30. Christin L., Wysong D., Meshulam T., et al. Human platelets damage Aspergillus fumigatus hyphae and may supplement killing by neutrophils. Infect Immun 66 (1998) 1181-1189